TREA

98716503 - GOLMAITA

Follow

Information

  • Trademark
  • 98716503
  • Serial Number
    98716503
  • Filing Date
    August 26, 2024
    a year ago
  • Transaction Date
    July 13, 2025
    5 months ago
  • Status Date
    July 12, 2025
    5 months ago
  • Location Date
    July 12, 2025
    5 months ago
  • Status Code
    645
  • Current Location
    TMO LAW OFFICE 123
    Employee Name
    COFFEY, AARON
  • Attorney Docket Number
    00164235-US
    Attorney Name
    Marilyn F. Kelly
    Law Office Assigned Location Code
    N50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
GOLMAITA
Case File Statements
  • GS0051: Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressant preparations, pharmaceutical antibodies for medical use, and immunotherapy preparations for the treatment of cancer; cytokine inhibitory drugs being pharmaceutical preparations for the treatment of cancer; anticoagulants; Pharmaceutical preparations for human use that modulate the immune system for the treatment of immune-system related diseases and disorders; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy for the treatment of cancer; Pharmaceutical and biological preparations for human use, namely, stem cells for medical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use; Pharmaceutical preparations for human use for the treatment of neuropsychiatric disorders; therapeutic radiopharmaceutical preparations for human use for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations for human use; diagnostic preparations for human use for medical purposes; radiopharmaceutical preparations for human use in the nature of imaging and detection agents for diagnosing and monitoring cancer; biological preparations for human use in the nature of radio-isotope markers for therapeutic or diagnostic use; Pharmaceutical preparations for human use for the treatment of cystic fibrosis
Case File Event Statements
  • 8/26/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/7/2025 - 10 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/9/2025 - 6 months ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/8/2025 - 10 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/8/2025 - 10 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/8/2025 - 10 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/8/2025 - 10 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/9/2025 - 6 months ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/9/2025 - 6 months ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/12/2025 - 5 months ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 7/12/2025 - 5 months ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 7/12/2025 - 5 months ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR